Size-tunable cancer nanotherapeutics
尺寸可调的癌症纳米疗法
基本信息
- 批准号:8098834
- 负责人:
- 金额:$ 32.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbraxaneAdverse effectsAllergicAllergic ReactionAnimal ModelArchitectureBiodistributionBreast Cancer ModelBreast Cancer TreatmentCanis familiarisCell surfaceCholic AcidsClinicalCremophorDataDevelopmentDrug Delivery SystemsDrug FormulationsDrug StabilityEncapsulatedEnvironmentEvaluationFDA approvedFaceFutureHistamineHourHumanImageIn VitroLabelLengthLigandsLinkLiquid substanceLiteratureLiverLysineMalignant NeoplasmsMammalsMicellesNamesNeoplasms in Vascular TissuePaclitaxelParticle SizePatientsPenetrationPermeabilityPharmaceutical PreparationsPhysical condensationPolyethylene GlycolsPolymersPowder dose formPrecipitationPremedicationPrincipal InvestigatorPropertyPublishingReactionReportingReticuloendothelial SystemScintillation CountingSerum AlbuminShapesSiteSolubilitySolventsSteroidsStructureSystemTestingTherapeuticToxic effectTransgenic MiceTransgenic OrganismsTreatment EfficacyWaterXenograft ModelXenograft procedureamphiphilicityaqueousbasecancer cellcancer typechemotherapeutic agentcremophor ELcytotoxicitydesignfunctional groupimprovedin vivomalignant breast neoplasmmouse modelnanocarriernanoformulationnanoparticlenanotherapeuticnoveloptical imagingphase 1 studyprogramspublic health relevancetherapeutic targettumortumor xenograft
项目摘要
The goal of our studies is to develop a quantitative understanding of tumor metastasis. As cell migration is the central part of metastasis, we are developing quantitative experimental and computational methods to study migration in three dimensional matrices. Our preliminary studies have indicated that cancer cell migration in two and three dimensional matrices is significantly different. The effects of matrix structure and mechanics as well as extracellular degradation by proteolytic enzymes can not be studied in existing two dimensional assays. This lack of information about key processes and variables leads to incomplete and inaccurate understanding. Our goal is to rectify these problems by quantifying tumor cell migration in native like three dimensional environments. In the proposed studies, we will develop a system level understanding of tumor cell migration. The individual and collective roles of cell adhesion, matrix composition, matrix structure and proteolysis will be studied in well established prostate cancer cell lines. This will be accomplished through the following specific aims: 1) Quantify the systematic interactions of integrins and extracellular matrix in regulating three -dimensional tumor cell motility, 2) Quantify the effects of extracellular matrix structure on protease activity in tumor cells and 3) Develop multi-scale computational models to predict and quantify cell adhesion and migration in three dimensional matrices. Our ability to combat and cure cancer rests on our understanding of the processes regulating metastasis. The project outlined in this proposal will be a significant step in reaching that level of understanding. By combining experiments and simulations, carried out in controlled environments that mimic in vivo settings, we will be able to quantify the individual and collective roles of matrix and cells in tumor cell migration. The systems level quantification achieved through our experiments and simulation will serve as a platform for discovery of anti- cancer therapeutics. Principal Investigator/Program Director (Last, first, middle): Zaman, Muhammad H., Ph.D..
我们研究的目标是发展对肿瘤转移的定量理解。由于细胞迁移是转移的中心部分,我们正在开发定量的实验和计算方法来研究三维矩阵中的迁移。我们的初步研究表明,癌细胞在二维和三维基质中的迁移是显着不同的。基质结构和力学以及蛋白水解酶的细胞外降解的影响不能在现有的二维测定中研究。缺乏关于关键流程和变量的信息导致不完整和不准确的理解。我们的目标是通过量化肿瘤细胞在天然三维环境中的迁移来纠正这些问题。在拟议的研究中,我们将开发肿瘤细胞迁移的系统水平的理解。细胞粘附、基质组成、基质结构和蛋白水解的个体和集体作用将在良好建立的前列腺癌细胞系中进行研究。这将通过以下具体目标来实现:1)量化整联蛋白和细胞外基质在调节三维肿瘤细胞运动性中的系统性相互作用,2)量化细胞外基质结构对肿瘤细胞中蛋白酶活性的影响,以及3)开发多尺度计算模型以预测和量化三维基质中的细胞粘附和迁移。我们对抗和治愈癌症的能力取决于我们对调节转移过程的理解。本提案中概述的项目将是达到这一理解水平的重要一步。通过结合实验和模拟,在模拟体内环境的受控环境中进行,我们将能够量化基质和细胞在肿瘤细胞迁移中的个体和集体作用。通过我们的实验和模拟实现的系统级量化将作为发现抗癌疗法的平台。主要研究者/项目负责人(最后,第一,中间):扎曼,穆罕默德H.,博士
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juntao Luo其他文献
Juntao Luo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juntao Luo', 18)}}的其他基金
An innovative hemoperfusion nanotrap for sepsis treatment.
用于脓毒症治疗的创新血液灌流纳米陷阱。
- 批准号:
10220077 - 财政年份:2018
- 资助金额:
$ 32.05万 - 项目类别:
An innovative hemoperfusion nanotrap for sepsis treatment.
用于脓毒症治疗的创新血液灌流纳米陷阱。
- 批准号:
9974537 - 财政年份:2018
- 资助金额:
$ 32.05万 - 项目类别:
Rational Design and High throughput synthesis of nanocarriers for efficient drug delivery
用于高效药物递送的纳米载体的合理设计和高通量合成
- 批准号:
9119009 - 财政年份:2015
- 资助金额:
$ 32.05万 - 项目类别:
Rational Design and High throughput synthesis of nanocarriers for efficient drug delivery
用于高效药物递送的纳米载体的合理设计和高通量合成
- 批准号:
8970069 - 财政年份:2015
- 资助金额:
$ 32.05万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Discovery Grants Program - Individual